Cargando…
Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors
Recent findings suggest that high-grade serous ovarian cancer can originate in the fallopian tube. Not only has that made the identification of precursor lesions pivotal in early detection and prevention of these cancers, prophylactic salpingectomy alongside hysterectomy for benign indications has b...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821201/ https://www.ncbi.nlm.nih.gov/pubmed/36615096 http://dx.doi.org/10.3390/jcm12010296 |
_version_ | 1784865640571469824 |
---|---|
author | Tchartchian, Garri Bojahr, Bernd Heils, Lucas Krentel, Harald De Wilde, Rudy L. |
author_facet | Tchartchian, Garri Bojahr, Bernd Heils, Lucas Krentel, Harald De Wilde, Rudy L. |
author_sort | Tchartchian, Garri |
collection | PubMed |
description | Recent findings suggest that high-grade serous ovarian cancer can originate in the fallopian tube. Not only has that made the identification of precursor lesions pivotal in early detection and prevention of these cancers, prophylactic salpingectomy alongside hysterectomy for benign indications has been increasingly proposed as well. The present prospective single-center study included 273 women who underwent opportunistic salpingectomy alongside laparoscopic supracervical hysterectomy. Uterine and tubal histopathological results as well as intra- and postoperative complications were evaluated. The complication rate was 3.3%, of which none were caused by salpingectomy. Uterine histopathology diagnosed 181 patients (66.8%) with uterine myomas, 60 patients (22.1%) with adenomyosis, 29 patients (10.7%) with adenomyomatosis, and, 1 patient (0.4%) without pathological abnormality. p53 signatures were detected in 221 right fallopian tubes (80.9%) and in 229 left tubes (83.9%). In total, 8 patients showed bilateral STIL (2.9%), whereas in 1 patient (0.4%) STIL was detected in the left tube only. No STIC were detected. Laparoscopic opportunistic salpingectomy is demonstrated to be both safe and feasible. It appears to be promising to reduce the risk for ovarian cancer, yet more studies are needed to undoubtedly confirm this. |
format | Online Article Text |
id | pubmed-9821201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98212012023-01-07 Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors Tchartchian, Garri Bojahr, Bernd Heils, Lucas Krentel, Harald De Wilde, Rudy L. J Clin Med Article Recent findings suggest that high-grade serous ovarian cancer can originate in the fallopian tube. Not only has that made the identification of precursor lesions pivotal in early detection and prevention of these cancers, prophylactic salpingectomy alongside hysterectomy for benign indications has been increasingly proposed as well. The present prospective single-center study included 273 women who underwent opportunistic salpingectomy alongside laparoscopic supracervical hysterectomy. Uterine and tubal histopathological results as well as intra- and postoperative complications were evaluated. The complication rate was 3.3%, of which none were caused by salpingectomy. Uterine histopathology diagnosed 181 patients (66.8%) with uterine myomas, 60 patients (22.1%) with adenomyosis, 29 patients (10.7%) with adenomyomatosis, and, 1 patient (0.4%) without pathological abnormality. p53 signatures were detected in 221 right fallopian tubes (80.9%) and in 229 left tubes (83.9%). In total, 8 patients showed bilateral STIL (2.9%), whereas in 1 patient (0.4%) STIL was detected in the left tube only. No STIC were detected. Laparoscopic opportunistic salpingectomy is demonstrated to be both safe and feasible. It appears to be promising to reduce the risk for ovarian cancer, yet more studies are needed to undoubtedly confirm this. MDPI 2022-12-30 /pmc/articles/PMC9821201/ /pubmed/36615096 http://dx.doi.org/10.3390/jcm12010296 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tchartchian, Garri Bojahr, Bernd Heils, Lucas Krentel, Harald De Wilde, Rudy L. Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors |
title | Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors |
title_full | Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors |
title_fullStr | Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors |
title_full_unstemmed | Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors |
title_short | Prophylactic Salpingectomy during Hysterectomy for Benign Disease: A Prospective Study to Evaluate High-Grade Serous Ovarian Carcinoma Precursors |
title_sort | prophylactic salpingectomy during hysterectomy for benign disease: a prospective study to evaluate high-grade serous ovarian carcinoma precursors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821201/ https://www.ncbi.nlm.nih.gov/pubmed/36615096 http://dx.doi.org/10.3390/jcm12010296 |
work_keys_str_mv | AT tchartchiangarri prophylacticsalpingectomyduringhysterectomyforbenigndiseaseaprospectivestudytoevaluatehighgradeserousovariancarcinomaprecursors AT bojahrbernd prophylacticsalpingectomyduringhysterectomyforbenigndiseaseaprospectivestudytoevaluatehighgradeserousovariancarcinomaprecursors AT heilslucas prophylacticsalpingectomyduringhysterectomyforbenigndiseaseaprospectivestudytoevaluatehighgradeserousovariancarcinomaprecursors AT krentelharald prophylacticsalpingectomyduringhysterectomyforbenigndiseaseaprospectivestudytoevaluatehighgradeserousovariancarcinomaprecursors AT dewilderudyl prophylacticsalpingectomyduringhysterectomyforbenigndiseaseaprospectivestudytoevaluatehighgradeserousovariancarcinomaprecursors |